Management of patients with type 2 diabetes and cardiovascular disease in primary care
Related Experiment Video
Updated: Nov 11, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Andrew Marson1, Natalie Raffoul2, Rawa Osman3
1BSc, PhD, Clinical Product Lead, NPS MedicineWise, NSW.
Insights
Many patients with diabetes and cardiovascular disease (CVD) are not receiving optimal risk factor management in Australian general practices. This highlights a need for improved medication prescribing and risk factor monitoring to reduce CVD deaths.
Area of Science:
- General Practice
- Cardiovascular Disease
- Diabetes Management
Background:
- Cardiovascular disease (CVD) accounts for a significant proportion of deaths in individuals with diabetes or pre-diabetes in Australia.
- Effective management of cardiovascular risk factors is crucial for this high-risk population.
Purpose of the Study:
- To examine the current management of cardiovascular risk factors in general practice for patients with both type 2 diabetes and CVD.
- To identify potential areas for improvement in patient care and risk reduction strategies.
Main Methods:
- A cross-sectional study utilizing data from 33,559 adult patients with type 2 diabetes and CVD.
- Data were sourced from the MedicineInsight general practice data program as of November 1, 2018.
Main Results:
- One-third of patients lacked records for all three recommended cardiovascular risk-reducing medications.
- Suboptimal monitoring and achievement of diabetes and cardiovascular risk factor targets were observed.
- Many patients on metformin-based therapy received glucose-lowering drugs lacking proven cardiovascular benefits.
Conclusions:
- General practices have opportunities to optimize the management of patients with diabetes and CVD.
- Utilizing datasets like MedicineInsight can aid in identifying patients who require proactive recall for improved care.
Background And Objectives:
Approximately 65% of cardiovascular disease (CVD)-related deaths in Australia occur in people with diabetes or pre-diabetes. The aim of this study was to investigate general practice management of risk factors among patients with both conditions.
Method:
This was a cross-sectional study of 33,559 adult patients with both type 2 diabetes and CVD at 1 November 2018, using the general practice data program MedicineInsight.
Results:
One-third of patients did not have a record in their current medications list for all three recommended medicines to reduce cardiovascular risk. Potentially suboptimal monitoring and achievement of targets for diabetes and cardiovascular risk factors was also identified. Most patients using metformin-based combination therapy were prescribed blood glucose-lowering medicines that do not have evidence of cardiovascular benefit.
Discussion:
These data suggest opportunities to support general practices to optimise patient management. Datasets such as MedicineInsight can help practices identify patients who may benefit from recall.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
05:06Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Atherosclerosis III: Management
Angina IV: Management
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Cardiomyopathy V: Interprofessional Care